Jean King

Prof. Jean King


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
JKJean King
Jean King
TGTimothy S. Garelick
Timothy S. Garelick
MBMathew E. Brevard
Mathew E. Brevard
WCWei Chen
Wei Chen
TMTara L. Messenger
Tara L. Messenger
CFCraig F. Ferris
Craig F. Ferris

1 June 2010 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
Nanyin ZhangNanyin Zhang
Nanyin Zhang
PRPallavi Rane
Pallavi Rane
WHWei Huang
Wei Huang
ZLZhifeng Liang
Zhifeng Liang
DKDavid Kennedy
David Kennedy
JKJean King
Jean King

1 February 2001 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
PDF file
JKJean King
Jean King
DMDeborah Mandansky
Deborah Mandansky
SKSusie King
Susie King
KFKennethe E. Fletcher
Kennethe E. Fletcher
JBJudith Brewer
Judith Brewer

9 February 2017 in JCI Insight
Verified
Journal Article
Open access
PDF file
DGDominic J. Gessler
Dominic J. Gessler
DLDanning Li
Danning Li
HXHongxia Xu
Hongxia Xu
QSQin Su
Qin Su
JSJulio Sanmiguel
Julio Sanmiguel
GGGuangping Gao
Guangping Gao
Canavan disease (CD) is a debilitating and lethal leukodystrophy caused by mutations in the aspartoacylase ( ASPA ) gene and the resulting defect in N -acetylaspartate (NAA) metabolism in the CNS and peripheral tissues. Recombinant adeno-associated virus (rAAV) has the ability to cross the blood-brain barrier and widely transduce the CNS. We developed a rAAV-based and optimized gene replacement therapy, which achieves early, complete, and sustained rescue of the lethal disease phenotype in CD mice. Our treatment results in a super-mouse phenotype, increasing motor performance of treated CD mice beyond that of WT control mice. We demonstrate that this rescue is oligodendrocyte independent, and that gene correction in astrocytes is sufficient, suggesting that the establishment of an astrocyte-based alternative metabolic sink for NAA is a key mechanism for efficacious disease rescue and the super-mouse phenotype. Importantly, the use of clinically translatable high-field imaging tools enables the noninvasive monitoring and prediction of therapeutic outcomes for CD and might enable further investigation of NAA-related cognitive function.

1 January 2000 in Behavioral Medicine
Verified
Journal Article
Closed access
JKJean King
Jean King
MRM C Rosal
M C Rosal
YMY Ma
Y Ma
GRG Reed
G Reed
TKT A Kelly
T A Kelly
IOI S Ockene
I S Ockene
Assessments of cortisol levels in saliva have been widely used by both researchers and clinicians as an index of adrenal functioning. Quarterly measurements of morning and evening cortisol levels were determined in a longitudinal study of 147 participants (72 women and 75 men) followed for I year each. The analysis of salivary cortisol revealed no significant gender or age differences in the sample. There was a sequence effect in quarterly cortisol values with a progressive decrease in serial measurements, especially notable in the morning values, as well as a seasonal variation in cortisol levels with significantly higher levels found in winter and fall, compared with spring and summer. The findings in this study suggest that repeated saliva sampling and seasonal variation in cortisol levels may independently affect adrenal response and, therefore, need to be accounted for in longitudinal studies.

1 December 2003 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JKJean King
Jean King
JTJeffrey Tenney
Jeffrey Tenney
VRVictoria Rossi
Victoria Rossi
LCLauralea Colamussi
Lauralea Colamussi
SBStacy Burdick
Stacy Burdick